Application Sponsors
ANDA 091657 | MYLAN INSTITUTIONAL | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 100MG/ML | 0 | TRANEXAMIC ACID | TRANEXAMIC ACID |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2011-11-03 | |
LABELING; Labeling | SUPPL | 2 | AP | 2015-09-29 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2018-05-14 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-10-19 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2022-06-23 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 6 | Null | 7 |
SUPPL | 9 | Null | 15 |
SUPPL | 10 | Null | 15 |
TE Codes
CDER Filings
MYLAN INSTITUTIONAL
cder:Array
(
[0] => Array
(
[ApplNo] => 91657
[companyName] => MYLAN INSTITUTIONAL
[docInserts] => ["",""]
[products] => [{"drugName":"TRANEXAMIC ACID","activeIngredients":"TRANEXAMIC ACID","strength":"100MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"TRANEXAMIC ACID","submission":"TRANEXAMIC ACID","actionType":"100MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)